Quantitative Systematic Strategies’s BioMarin Pharmaceuticals BMRN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-8,000
| Closed | -$604K | – | 484 |
|
|
2021
Q1 | $604K | Sell |
8,000
-4,360
| -35% | -$329K | 0.09% | 331 |
|
|
2020
Q4 | $1.08M | Buy |
12,360
+1,108
| +10% | +$97.2K | 0.15% | 222 |
|
|
2020
Q3 | $856K | Sell |
11,252
-1,681
| -13% | -$128K | 0.15% | 200 |
|
|
2020
Q2 | $1.6M | Buy |
12,933
+5,274
| +69% | +$650K | 0.32% | 89 |
|
|
2020
Q1 | $647K | Sell |
7,659
-3,842
| -33% | -$325K | 0.53% | 58 |
|
|
2019
Q4 | $972K | Sell |
11,501
-1,996
| -15% | -$169K | 0.14% | 227 |
|
|
2019
Q3 | $910K | Buy |
+13,497
| New | +$910K | 0.21% | 145 |
|
|
2016
Q3 | – | Sell |
-12,716
| Closed | -$996K | – | 386 |
|
|
2016
Q2 | $996K | Buy |
12,716
+9,405
| +284% | +$737K | 0.47% | 47 |
|
|
2016
Q1 | $259K | Buy |
3,311
+459
| +16% | +$35.9K | 0.1% | 220 |
|
|
2015
Q4 | $301K | Buy |
+2,852
| New | +$301K | 0.08% | 753 |
|
|
2015
Q3 | – | Sell |
-3,585
| Closed | -$480K | – | 378 |
|
|
2015
Q2 | $480K | Sell |
3,585
-1,135
| -24% | -$152K | 0.11% | 316 |
|
|
2015
Q1 | $610K | Buy |
4,720
+1,226
| +35% | +$158K | 0.17% | 174 |
|
|
2014
Q4 | $319K | Sell |
3,494
-782
| -18% | -$71.4K | 0.13% | 219 |
|
|
2014
Q3 | $311K | Buy |
+4,276
| New | +$311K | 0.18% | 208 |
|